Investment
Features
FeesSafety
Academy
More
Pluang+

Generac to release Q3 2026 earnings on Oct 28 with a conference call at 10 a.m. EDT

Company Fundamentals
14 Oct 2026
GlobeNewsWire
View Source
Neutral
Generac to release Q3 2026 earnings on Oct 28 with a conference call at 10 a.m. EDT

Generac Holdings Inc. announced it will release its third quarter 2026 financial results before the market opens on October 28, 2026. The company will host a conference call at 10 a.m. EDT the same day to discuss the earnings highlights. Investors can access the live webcast via Generac’s website or the provided link, with a replay available afterward. This update is important for stakeholders to assess Generac's financial health and business outlook in the energy technology sector.

Generac's upcoming Q3 2026 earnings release and call provide context for readers. For those tracking Industrials, 92 of 136 US stocks rose and 33 fell on Pluang. Notable movers include CXW at USD 33.50 (-1.56%), INIO at USD 18.59 (+1.53%), and SUNB at USD 78.41 (+1.40%) with a typical hold time of 5 days, as of Oct 14, 2026 15:21 WIB.

More News

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall Ltd. has emerged from stealth with $4 million in pre-seed funding to develop AI-powered autonomous attack agents that simulate real-world cyberattacks on enterprises. These agents start from outside the network with no insider access, contin...

Others
Bullish
1 hour ago
Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics has appointed John O’Malley, M.D., Ph.D., as its Chief Medical Officer. Dr. O’Malley brings extensive experience in immunology and clinical development from his previous roles at CRISPR Therapeutics and Sanofi. His leadership ...

Market News
Bullish
2 hours ago
FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...

Market News
Bullish
2 hours ago
DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global Inc. will announce its financial results for the third quarter ending September 30, 2026, on October 27 after the stock market closes. The company will hold a conference call and webcast to discuss the results, providing investors with ins...

Company Fundamentals
Neutral
2 hours ago
Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware introduced its Model Context Protocol (MCP) Server Protection solution to help organizations secure the integration layer where AI agents connect to enterprise applications and workflows. This new security tool provides visibility into MCP in...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App